<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02714673</url>
  </required_header>
  <id_info>
    <org_study_id>ADECRO</org_study_id>
    <nct_id>NCT02714673</nct_id>
  </id_info>
  <brief_title>Management of Patients on Long Term Anticoagulation Therapy Undergoing a Primary Total Hip of Knee Replacement</brief_title>
  <acronym>ADELC</acronym>
  <official_title>Management of Patients on Long Term Anticoagulation Therapy Undergoing a Primary Total Hip of Knee Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association pour le Développement et l'Enseignement de la Chirurgie Réparatrice et Orthopédique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association pour le Développement et l'Enseignement de la Chirurgie Réparatrice et Orthopédique</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is a multicenter, prospective, observational study of standard care. This study analyses
      the care of patients on long term effective anticoagulation therapy (ADELC) during a primary
      hip or knee arthroplasty.

      The objectives of the study are to:

        1. Identify clinical practices set up for patient care

        2. Assess the type and the frequency of perioperative complications

        3. Look for factors, related to patients or treatments, associated with the occurrence of
           these complications.

      The main objective is to estimate the risks, adjusted and not, of postoperative complications
      associated to a long term anticoagulation by comparing patients under anticoagulation to a
      control group of patients having the same interventions but who are not under
      anticoagulation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 1, 2016</start_date>
  <completion_date type="Anticipated">July 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>a composite criteria including the occurrence of one or more bleeding complications, major thrombotic events, or reoperation for any reason</measure>
    <time_frame>up to 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The length of hospital stay</measure>
    <time_frame>until end of study, an expected 12 months</time_frame>
    <description>this is a continuous outcome measured. It measures the number of days from date of entry to the date of hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportion of patients who are transfused during the hospitalization</measure>
    <time_frame>up to day 15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The occurrence of a complication of grade 2 or more from Dindo and Clavien classification .</measure>
    <time_frame>within 12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>ADELC</arm_group_label>
    <description>Cohort of patients on long term anticoagulation and undergoing a primary hip or knee replacement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL</arm_group_label>
    <description>Cohort of patients not on long term anticoagulation and undergoing a primary hip or knee replacement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>anticoagulation</intervention_name>
    <description>anticoagulation refers to any long term effective anticoagulation including antivitamin K, direct oral anticoagulants. Aspirin, clopidogrel are not included</description>
    <arm_group_label>ADELC</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients on long term effective anticoagulation (ADELC) or not undergoing a primary hip or
        knee replacement
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult ≥ 18 years

          -  Programmed for primary hip or knee arthroplasty.

          -  Effective dose of anticoagulant drugs intake for more than 1 month with the intention
             to resume it after the intervention for ADELC cohort; no effective dose of
             anticoagulant drugs intake for the control cohort.

        Exclusion Criteria:

          -  Patient non opposition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <state>IDF</state>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Biau</last_name>
      <email>david.biau@aphp.Fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2016</study_first_submitted>
  <study_first_submitted_qc>March 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2016</study_first_posted>
  <last_update_submitted>July 3, 2017</last_update_submitted>
  <last_update_submitted_qc>July 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Association pour le Développement et l'Enseignement de la Chirurgie Réparatrice et Orthopédique</investigator_affiliation>
    <investigator_full_name>Dr David BIAU</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

